Arkolith/Insider Trading/CMMB/Form 4

OrbiMed Israel BioFund GP Limited Partnership

10% OwnerChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Jan 5, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2023Sell(S)71K$4.51$318K2.2M
Jan 3, 2023Sell(S)266K$3.34$890K2.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-23-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML